Subtype
Human Papillomavirus-Related Malignant Neoplasm
CI-CAN-00002898Explore in graph →
70 active trials
- NCIt
- C27718
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002898Explore in graph →
Clinical trials
168 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (15)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06454175 | A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years | unknown | Phase 1 | 72 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jan 6, 2025 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT03226470 | Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions | unknown | Phase 1 | 40 | Huazhong University of Science and TechnologyOTHER | 1 | Jan 14, 2022 | clinicaltrials |
| NCT02800369 | Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions | unknown | Phase 1 | 20 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 12, 2017 | clinicaltrials |
| NCT03057912 | A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ | unknown | Phase 1 | 60 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jun 9, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jan 6, 2025source: clinicaltrials